MRK vs MDT
By Alex · Tickerpine
Merck & Co., Inc. vs Medtronic plc, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | MRK | MDT |
|---|---|---|
| Price | $148.69 | $89.50 |
| Market cap | $366.84B | $114.48B |
| P/E ratio | 119.0 | 21.8 |
| ROE | 6.96% | 10.65% |
| Profit margin | 4.77% | 13.93% |
| Revenue growth | 5.10% | 13.70% |
| Dividend yield | 2.29% | 3.22% |
| Beta | 0.23 | 0.57 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
MRK vs MDT in plain English
- MRK is the bigger company — about 3.2× the market cap of MDT.
- MDT is cheaper on earnings (P/E 21.8 vs 119.0).
- MDT earns a higher return on equity (11% vs 7%).
- MDT is growing revenue faster (14% vs 5%).
- MDT has the higher dividend yield (3.22% vs 2.29%).
How would $1,000 have done in each?
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
MDT return calculator
See what $1,000 in Medtronic plc would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.